4.2
La bronchopneumopathie chronique obstructive II : Physiopathologie
La physiopathologie de la bronchopneumopathie chronique obstructive (BPCO) est complexe et multiforme, impliquant une interaction complexe entre diver…
La bronchopneumopathie chronique obstructive, ou BPCO, est principalement causée par une inflammation chronique des voies respiratoires due à l’exposition à des irritants tels que la fumée de cigarette, la poussière ou la pollution de l’air.
Les cellules inflammatoires, y compris les lymphocytes, les macrophages et les neutrophiles, envahissent la paroi des voies respiratoires, libérant des médiateurs nocifs comme les leucotriènes et les cytokines.
Les particules inhalées et les oxydants produits par ces cellules inflammatoires aggravent l’inflammation.
Les oxydants inhibent les composés antiprotéases qui protègent contre la dégradation du tissu pulmonaire.
Simultanément, ils augmentent l’activité des protéases, des enzymes qui dégradent le tissu pulmonaire.
Ce déséquilibre perturbe l’équilibre naturel entre les protéases et les antiprotéases, entraînant la détérioration des alvéoles et la perte d’élasticité des poumons.
En conséquence, les voies respiratoires se rétrécissent, obstruant la circulation de l’air, ce qui favorise la production excessive de mucus et provoque une accumulation de liquide dans les poumons.
Dans la BPCO, l’inflammation chronique provoque un stress oxydatif, libérant des radicaux libres qui endommagent le tissu pulmonaire, entraînant la formation de bulles et la détérioration de la paroi alvéolaire, altérant les échanges gazeux.
View the full transcript and gain access to JoVE Core videos
Q1: What causes chronic airway inflammation in COPD?
COPD develops from chronic exposure to irritants like cigarette smoke, dust, and air pollution. These irritants trigger inflammatory cells—lymphocytes, macrophages, and neutrophils—to infiltrate airway walls and release harmful mediators such as leukotrienes and cytokines. This perpetuates ongoing inflammation and progressive lung damage characteristic of the disease.
Q2: How does the protease-antiprotease imbalance damage lung tissue in COPD?
Oxidants from cigarette smoke impair antiproteases like alpha-1 antitrypsin that normally protect lung tissue. Simultaneously, oxidants increase protease activity, particularly elastase, which degrades extracellular matrix components. This imbalance causes destruction of alveolar walls and lung parenchyma, leading to emphysema and loss of lung elasticity.
Q3: What role do free radicals play in COPD pathophysiology?
Chronic inflammation generates reactive oxygen species (ROS) like superoxide anions and hydroxyl radicals from cigarette smoke and inflammatory cells. These free radicals damage cellular structures, proteins, lipids, and DNA, further promoting inflammation and lung tissue deterioration. This oxidative stress perpetuates the cycle of tissue destruction in COPD.
Q4: How does airway narrowing occur in COPD?
Chronic inflammation causes structural changes and constriction in airways, reducing airflow. Mucus hypersecretion and mucosal edema exacerbate narrowing, while smooth muscle constriction further impedes airflow. Additionally, increased vascular permeability from inflammation leads to fluid accumulation in lungs, contributing to obstruction and airway blockage.
Q5: What structural changes occur in the lungs during COPD?
Ongoing tissue destruction causes alveolar enlargement and bullae formation—large air pockets within lung tissue. Destruction of alveolar walls reduces surface area for gas exchange, impairing oxygen uptake and carbon dioxide elimination. These structural changes decrease lung compliance and elasticity, leading to reduced oxygen uptake and shortness of breath.
Q6: How do inflammatory mediators perpetuate lung damage in COPD?
Inflammatory cells release cytokines, leukotrienes, and other mediators that perpetuate the inflammatory response. These mediators recruit additional inflammatory cells and sustain the release of proteases and oxidants. This creates a self-perpetuating cycle of inflammation and tissue destruction that characterizes COPD progression.
Q7: Why is gas exchange impaired in COPD?
Destruction of alveolar walls reduces the surface area available for oxygen and carbon dioxide exchange. Combined with fluid accumulation and airway obstruction, these structural changes impair gas exchange efficiency. Understanding these mechanisms is essential for developing effective chronic obstructive pulmonary disease management strategies.